Radiomics analysis of intratumoral and different peritumoral regions from multiparametric MRI for evaluating HER2 status of breast cancer: A comparative study

Purpose: To investigate the potential of radiomics signatures (RSs) from intratumoral and peritumoral regions on multiparametric magnetic resonance imaging (MRI) to noninvasively evaluate HER2 status in breast cancer. Method: In this retrospective study, 992 patients with pathologically confirmed breast cancers who underwent preoperative MRI were enrolled. The breast cancer lesions were segmented manually, and the intratumor region of interest (ROI Intra ) was dilated by 2, 4, 6 and 8 mm (ROI Peri2mm , ROI Peri4mm , ROI Peri6mm , and ROI Peri8mm , respectively). Quantitative radiomics features were extracted from dynamic contrast -enhanced T1 -weighted imaging (DCE-T1), fat -saturated T2 -weighted imaging (T2) and diffusion -weighted imaging (DWI). A three -step procedure was performed for feature selection, and RSs were constructed using a support vector machine (SVM) to predict HER2 status. Result: The best single -area RSs for predicting HER2 status were DCE_Peri4mm-RS, T2_Peri4mmRS, and DWI_Peri4mm-RS, yielding areas under the curve (AUCs) of 0.716 (95% confidence interval (CI), 0.648 -0.778), 0.706 (95% CI, 0.637 -0.768), and 0.719 (95% CI, 0.651 -0.780), respectively, in the test set. The optimal RSs combining intratumoral and peritumoral regions for evaluating HER2 status were DCE-T1_Intra + DCE_Peri4mm-RS, T2_Intra + T2_Peri6mm-RS and DWI_Intra + DWI_Peri4mm-RS, with AUCs of 0.752 (95% CI, 0.686 -0.810), 0.754 (95% CI, 0.688 -0.812) and 0.725 (95% CI, 0.657 -0.786), respectively, in the test set. Combining three sequences in the ROI Intra , ROI Peri2mm , ROI Peri4mm , ROI Peri6mm and ROI Peri8mm areas, the optimal RS was DCE-T1_Peri4mm + T2_Peri4mm + DWI_Peri4mm-RS, achieving an AUC of 0.795 (95% CI, 0.733 -0.849) in the test set. Conclusion: This study systematically explored the influence of the intratumoral region, different peritumoral sizes and their combination in radiomics analysis for predicting HER2 status in breast cancer based on multiparametric MRI and found the optimal RS.